Psychedelic Science Newsletter
Issue #49August 3, 20267 studies

Psilocybin stays active in neurons long after it leaves the bloodstream — here's what that means

Psychedelic and ketamine research had a genuinely strange week — strange in the good, paradigm-shifting sense.

From a mushroom that produces both psilocybin and deadly toxins to ketamine hiding inside neurons long after your blood runs clean, the field keeps finding that the obvious explanations aren't quite right.

Ketamine Doesn't Leave When You Think It Does 🧠

  • Researchers built fluorescent sensors — called iKetSnFRs — that track ketamine inside living neurons with cellular and subcellular precision, in real time.
  • The surprising part: ketamine persisted inside neuronal compartments well after it was undetectable in blood, at the plasma membrane, and on brain electrical recordings. It showed up in nine distinct organelles, each with its own engagement pattern.
  • This means the drug's famous "rapid and sustained" antidepressant effect may be driven less by what happens at the cell surface and more by what's happening deep inside the cell — long after the dose.

Why it matters: Every current model of how ketamine works assumes the plasma membrane is the main stage. These findings suggest the intracellular story may be just as important.

🔗 Research square Preprint 🗓️ Aug 1

Key Findings

Psilocybin and Ketamine Share a Surprising Immune Fingerprint

  • Despite hitting completely different receptors, both psilocybin and ketamine converged on the same immune signaling pathways in a multi-method study using spinal fluid proteomics, stem cell models, and brain imaging.
  • A cytokine ratio tied to IL-7 and IL-15 signaling predicted who responded to ketamine — and who didn't — suggesting immune rebalancing may be part of how rapid-acting antidepressants work.
💡 Two very different drugs, one shared immune signal worth watching.
🥈 Top 2% journal 🔗 Molecular psychiatry Journal Article 🗓️ Jul 28

Psilocybin's Effect on the Brain Depends on Whether You're Awake and Still

  • In mice, psilocybin increased calcium signaling in the tips of cortical neurons — but only during quiet wakefulness, not active movement. Remove the relevant serotonin receptor and the effect disappears entirely.
  • Psilocybin also altered the normal relationship between that acute calcium activity and the long-term structural changes (new spine formation) that usually follow it, suggesting psychedelic-induced plasticity follows different rules than ordinary learning.
💡 Brain state at the time of dosing may shape what psilocybin actually does.

Veterans With Severe PTSD Showed Meaningful Improvement After Psilocybin Therapy

  • An open-label pilot tested psilocybin-assisted therapy in U.S. military veterans with severe, treatment-resistant PTSD — a population previously unstudied with this approach and one that carries higher baseline suicide risk.
  • Early results showed the intervention was feasible and safe in this group, with preliminary clinical improvements in PTSD symptoms.
💡 Feasibility confirmed in a high-risk group that clinical trials typically exclude.
🥉 Top 5% journal 🔗 Communications medicine Journal Article 🗓️ Jul 30

Microdosing Psilocybin Left Lasting Marks on Rat Brain Cells

  • Repeated low doses of psilocybin — sub-perceptual, the kind used in microdosing — produced epigenetic changes in the medial prefrontal cortex of rats, meaning the drug altered how genes in that region are expressed without changing the DNA itself.
  • The findings add a molecular layer to microdosing research, which has mostly focused on behavior rather than what's happening at the cellular level.
💡 Microdosing may leave a molecular trace even when the effects feel invisible.
Top 20% journal 🔗 Psychopharmacology Journal Article 🗓️ Jul 28

There's a Mushroom That Makes Both Psilocybin and Deadly Poison

  • Researchers confirmed that Galerina indica — dubbed the "dark magic mushroom" — produces both psilocybin and amatoxins, the compounds responsible for most fatal mushroom poisonings. No single species had been shown to contain both before.
  • Genomic analysis suggests psilocybin biosynthesis arrived later via horizontal gene transfer, and its arrival may have coincided with reduced amatoxin potency — though what that trade-off means ecologically remains open.
💡 Nature's most famous psychedelic and its deadliest mushroom toxin now share an address.

Music During Psilocybin Sessions Does More Than Set the Mood

  • In a randomized controlled trial for depression and anxiety linked to life-threatening illness, 31 participants described music during psilocybin sessions as actively shaping their inner experience — connecting to physical, emotional, and existential layers simultaneously.
  • Participants reported feeling more intensely connected to music during psilocybin sessions than during control sessions, and many described music as something they could return to afterward to re-access the session's insights.
💡 Music in psychedelic therapy looks less like ambiance and more like an active ingredient.
🔗 Journal of music therapy Randomized Controlled Trial 🗓️ Jul 28

Implications

The week's findings share a common thread: the obvious mechanism is rarely the whole story. Ketamine hides in organelles, psilocybin rewires plasticity rules, and immune signals bridge two drugs that look nothing alike. The unresolved tension is whether these deeper mechanisms are what actually drive clinical response — or interesting biology that doesn't change the outcome.

Studies in this issue

Primary sources used for this newsletter.

  1. Ketamine stays inside nerve cells long after it leaves the bloodstream
    main storyResearch square2026-08-01PMID 42539064
  2. Long-term low-dose psilocybin causes gene regulation changes in the thinking areas of rat brains
    key findingPsychopharmacology2026-07-28PMID 42517891
  3. Psychedelic drugs affect nerve cell branches differently depending on behavior and serotonin receptors
    key findingbioRxiv : the preprint server for biology2026-08-01PMID 42539178
  4. Safety, practicality, and early results of psilocybin therapy for veterans with severe, hard-to-treat PTSD
    key findingCommunications medicine2026-07-30PMID 42533157
  5. "Dark magic mushroom" produces both deadly toxins and psychedelic compounds
    key findingbioRxiv : the preprint server for biology2026-08-01PMID 42539197
  6. Shared brain-immune signaling linked to fast antidepressant effects of ketamine and psychedelics
    key findingMolecular psychiatry2026-07-28PMID 42521762
  7. Participants’ Music Experiences During Psychedelic Therapy for Life-Threatening Illness
    key findingJournal of music therapy2026-07-28PMID 42517555

Continue reading

All Psychedelic Science issues